Cited by 355Nitric Oxide and Endothelin EffectsCancer-related gene regulationCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Open access

Böger, Rainer H., Sullivan, Lisa M., Schwedhelm, Edzard, Wang, Thomas J., Maas, Renke, Benjamin, Emelia J., Schulze, Friedrich, Xanthakis, Vanessa, Benndorf, Ralf A., Vasan, Ramachandran S.·2009·Circulation

DOI 10.1161/circulationaha.108.838268PMC PMC2742491

Open this paper in CoChat — free account

Abstract

Background— Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, induces endothelial dysfunction. Although elevated ADMA has been associated with an increased risk of cardiovascular disease events and death in referral samples, the prognostic significance of ADMA in the community has not been adequately evaluated. Methods and Results— We related plasma ADMA, l -arginine (Arg), and the ratio of Arg to ADMA to the incidence of cardiovascular disease (fatal or nonfatal myocardial infarction, coronary insufficiency, angina pectoris, stroke or transient ischemic attack, intermittent claudication, or heart failure) and death in 3320 Framingham Offspring Study participants (1769 women; mean age, 59 years). Over a follow-up period of 10.9 years, 281 individuals of 2956 free of cardiovascular disease at baseline developed incident cardiovascular disease, and 285 participants died. In multivariable models adjusting for established risk factors and other biomarkers (B-type natriuretic peptide, renin, homocysteine, urine albumin excretion, and C-reactive protein), ADMA and the ratio of Arg to ADMA were significantly associated with all-cause mortality (adjusted-hazard ratio [HR] per 1-SD increment, 1.21; 95% CI, 1.07 to 1.37; and HR per 1-SD increment, 0.80; 95% CI, 0.69 to 0.93, respectively), whereas Arg was not (HR per 1-SD increment, 0.89; 95% CI, 0.77 to 1.02). We noted effect modification by diabetes status; ADMA was associated with death in individuals without diabetes (adjusted HR per 1-SD increment, 1.30; 95% CI, 1.13 to 1.50) but not in individuals with diabetes (adjusted HR per 1-SD increment, 0.85; 95% CI, 0.62 to 1.16). ADMA, Arg, and the ratio of Arg to ADMA were not associated with cardiovascular disease incidence ( P >0.10). Conclusions— In our large community-based sample, ADMA was significantly associated with all-cause mortality, particularly in nondiabetic individuals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.838268

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease
Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
Kannel, W. B., Feinleib, M., McNAMARA, P. M., Garrison, R. J., & Castelli, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,639
L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation
Palmer, R. M. J., Rees, D. D., Ashton, D. S., & Moncada, S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81362-7 · Cited by 1,348
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P. N., Larson, M. G., Tofler, G. H., Levy, D. A., Newton‐Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,337
Self-citation
Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia
Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087
Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase
Achan, V., Broadhead, M., Malaki, M., Whitley, G. S. J., LEIPER, J. M., MacAllister, R. J., & Vallance, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593

Flagged first, then by citations

Show all 41 references

1 of the 41 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

10.1161/res.87.2.99 · DOI
10.1161/circ.98.18.1842 · DOI
10.1161/circ.101.16.1899 · DOI
10.1161/res.77.3.510 · DOI

Sorted by citations

Nitric oxide synthases: regulation and function
Forstermann, U., & Sessa, W. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr304 · Cited by 4,409
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses
Fernández-Macías, J. C., Ochoa-Martínez, A. C., Varela-Silva, J. A., & Pérez-Maldonado, I. N. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.009 · Cited by 458
Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: Possible therapeutic targets?
Rochette, L., Lorin, J., Zeller, M., Guilland, J.-C., Lorgis, L., Cottin, Y., & Vergely, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.07.004 · Cited by 456
Endothelial dysfunction : the early predictor of atherosclerosis
Mudau, M., Genis, A., Lochner, A., & Strijdom, H. (2012) · Cardiovascular Journal of Africa · doi:10.5830/cvja-2011-068 · Cited by 521
Cutaneous Vasodilator and Vasoconstrictor Mechanisms in Temperature Regulation
Johnson, J. M., Minson, C. T., & Kellogg, D. L. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130015 · Cited by 483
Cellular ADMA: Regulation and action
Teerlink, T., Luo, Z., Palm, F., & Wilcox, C. S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.08.002 · Cited by 351
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
Shah, N. H., LePendu, P., Bauer‐Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J. R., Nead, K. T., Cooke, J. P., & Leeper, N. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124653 · Cited by 332
Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation
Lekakis, J. P., Abraham, P., Balbarini, A., Blann, A. D., Boulanger, C. M., Cockcroft, J., Cosentino, F., Deanfield, J. E., Gallino, A., Ikonomidis, I., et al. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/1741826711398179 · Cited by 322
The role of asymmetric and symmetric dimethylarginines in renal disease
Schwedhelm, E., & Böger, R. H. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.31 · Cited by 262
Self-citation
Unexpected Effect of Proton Pump Inhibitors
Ghebremariam, Y. T., LePendu, P., Lee, J. C., Erlanson, D. A., Slaviero, A., Shah, N. H., LEIPER, J. M., & Cooke, J. P. (2013) · Circulation · doi:10.1161/circulationaha.113.003602 · Cited by 258
Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk
Böger, R. H., Maas, R., Schulze, F., & Schwedhelm, E. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.07.001 · Cited by 205
Self-citation
Endothelial Function
Vita, J. A. (2011) · Circulation · doi:10.1161/circulationaha.111.078824 · Cited by 195
Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism
Fleißner, F., Jazbutyte, V., Fiedler, J., Gupta, S. K., Yin, X., Xu, Q., Galuppo, P., Kneitz, S., Mayr, M., Ertl, G., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.216770 · Cited by 183
Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective Studies
Schlesinger, S., Sonntag, S. R., Lieb, W., & Maas, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165811 · Cited by 171
Self-citation
Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta‐Analysis of 22 Prospective Studies
Willeit, P., Freitag, D. F., Laukkanen, J. A., Chowdhury, S., Gobin, R., Mayr, M., Angelantonio, E. D., & Chowdhury, R. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001833 · Cited by 161
Metabolic reprogramming, oxidative stress, and pulmonary hypertension
Pokharel, M. D., Marciano, D. P., Fu, P., Franco, M. C., Unwalla, H. J., Tieu, K., Fineman, J. R., Wang, T., & Black, S. M. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102797 · Cited by 157
Self-citation
Oral supplementation with a combination of l-citrulline and l-arginine rapidly increases plasma l-arginine concentration and enhances NO bioavailability
Morita, M., Hayashi, T., Ochiai, M., Maeda, M., Yamaguchi, T., Ina, K., & Kuzuya, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.029 · Cited by 140
Dimethylarginine Dimethylaminohydrolase-1 Is the Critical Enzyme for Degrading the Cardiovascular Risk Factor Asymmetrical Dimethylarginine
Hu, X., Atzler, D., Xu, X. Y., Zhang, P., Guo, H., Lu, Z., Fassett, J., Schwedhelm, E., Böger, R. H., Bache, R. J., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.222638 · Cited by 138
Self-citation
Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease
Liu, X., Xu, X. Y., Shang, R., & Chen, Y. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.06.004 · Cited by 134
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
Finkelman, B. S., Putt, M., Wang, T., Wang, L., Narayan, H., Domchek, S. M., DeMichele, A. M., Fox, K. R., Matro, J. M., Shah, P. D., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.019 · Cited by 124
Self-citation
Targeted Metabolomic Evaluation of Arginine Methylation and Cardiovascular Risks
Wang, Z., Tang, W. H. W., Cho, L., Brennan, D. M., & Hazen, S. L. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.185645 · Cited by 124
Review article: Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus
Anderssohn, M., Schwedhelm, E., Lüneburg, N., Vasan, R. S., & Böger, R. H. (2010) · Diabetes and Vascular Disease Research · doi:10.1177/1479164110366053 · Cited by 114
Self-citation
Clinical Significance of Endothelial Dysfunction in Essential Hypertension
Gkaliagkousi, Ε., Gavriilaki, E., Triantafyllou, Α., & Δούμα, Σ. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0596-3 · Cited by 112
Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients
Tripepi, G. L., Mattace-Raso, F. U. S., Sijbrands, E. J. G., Seck, S. M., Maas, R., Böger, R. H., Witteman, J. C. M., Rapisarda, F., Malatino, L., Mallamaci, F., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11291210 · Cited by 114
Self-citation
Long-Term Impacts of Preeclampsia on the Cardiovascular System of Mother and Offspring
Yang, C., Baker, P. N., Granger, J. P., Davidge, S. T., & Tong, C. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21061 · Cited by 125
Chronic heart failure and aging – effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study
Sandri, M., Viehmann, M., Adams, V., Rabald, K., Mangner, N., Höllriegel, R., Lurz, P. C., Erbs, S., Linke, A., Kirsch, K., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315588391 · Cited by 110
Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer’s Disease
Fiandaca, M. S., Zhong, X., Cheema, A. K., Orquiza, M. H., Chidambaram, S., Tan, M. T., Gresenz, C. R., Fitzgerald, K. T., Nalls, M. A., Singleton, A., et al. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00237 · Cited by 107
Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure
García‐Martínez, R., Andreola, F., Mehta, G., Poulton, K., Oria, M., Jover‐Cobos, M., Soeda, J., Macnaughtan, J., Chiara, F. D., Habtesion, A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.031 · Cited by 106
Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation
Hijazi, Z., Oldgren, J., Siegbahn, A. G., & Wallentin, L. C. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.255182 · Cited by 104
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF‐β1 synthesis
Mihout, F., Shweke, N., Bigé, N., Jouanneau, C., Dussaule, J., Ronco, P. M., Chatziantoniou, C., & Boffa, J. (2010) · The Journal of Pathology · doi:10.1002/path.2769 · Cited by 98
Nitric Oxide Synthase Inhibitors as Antidepressants
Wegener, G., & Volke, V. (2010) · Pharmaceuticals · doi:10.3390/ph3010273 · Cited by 94
The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V
Pablo-Moreno, J. A. D., Serrano, L. J., Revuelta, L., Sánchez, M. J., & Liras, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158283 · Cited by 101
Homoarginine and Cardiovascular Outcome in the Population-Based Dallas Heart Study
Atzler, D., Gore, M. O., Ayers, C. R., Choe, C., Böger, R. H., de Lemos, J. A., McGuire, D. K., & Schwedhelm, E. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304398 · Cited by 89
Self-citation
L-Citrulline: A Non-Essential Amino Acid with Important Roles in Human Health
Aguayo, E., Martínez‐Sánchez, A., Fernández-Lobato, B., & Alacid, F. (2021) · Applied Sciences · doi:10.3390/app11073293 · Cited by 96
Endogenous Nitric Oxide Synthase Inhibitors in the Biology of Disease
Caplin, B., & LEIPER, J. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.247726 · Cited by 92
Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke
Chen, S., Li, N., Deb‐Chatterji, M., Dong, Q., Kielstein, J. T., Weißenborn, K., & Worthmann, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131215983 · Cited by 84
The biochemistry, measurement and current clinical significance of asymmetric dimethylarginine
Blackwell, S. (2009) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2009.009196 · Cited by 84
Reference Intervals for Plasma L-Arginine and the L-Arginine:Asymmetric Dimethylarginine Ratio in the Framingham Offspring Cohort
Lüneburg, N., Xanthakis, V., Schwedhelm, E., SULLIVAN, L. M., Maas, R., Anderssohn, M., Riederer, U., Glazer, N. L., Vasan, R. S., & Böger, R. H. (2011) · Journal of Nutrition · doi:10.3945/jn.111.148197 · Cited by 86
Self-citation
Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine
Ahmetaj‐Shala, B., Kirkby, N. S., Knowles, R., Al-Yamani, M., Mazi, S. I., Wang, Z., Tucker, A. T., Mackenzie, L. S., Armstrong, P. C. J., Nüsing, R. M., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.011591 · Cited by 84
Alanine-Glyoxylate Aminotransferase-2 Metabolizes Endogenous Methylarginines, Regulates NO, and Controls Blood Pressure
Caplin, B., Wang, Z., Slaviero, A., Tomlinson, J. A. P., Dowsett, L., Delahaye, M., Salama, A. D., Wheeler, D. C., & LEIPER, J. M. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.254078 · Cited by 83
Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography
Lu, T., Chung, M., Lin, M., Hsu, C., & Lin, S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.120 · Cited by 77
Interrelationship of Multiple Endothelial Dysfunction Biomarkers with Chronic Kidney Disease
Chen, J., Hamm, L. L., Mohler, E. R., Hudaihed, A., Arora, R., Chen, C.-S., Liu, Y., Browne, G., Mills, K. T., Kleinpeter, M. A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132047 · Cited by 76
Asymmetric Dimethylarginine and Clinical Outcomes in Chronic Kidney Disease
Lu, T., Chung, M., Lin, C., Hsu, C., & Lin, S. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08490910 · Cited by 76
Translating Metabolomics to Cardiovascular Biomarkers
Senn, T. N., Hazen, S. L., & Tang, W. H. W. (2012) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2012.06.004 · Cited by 71
Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro‐esophageal reflux disease: a meta‐analysis
Sun, S., Cui, Z.-M., Zhou, M., Li, R., Li, H., Zhang, S., Ba, Y., & Cheng, G. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12926 · Cited by 69
Symmetrical Dimethylarginine Predicts Mortality in the General Population
Gore, M. O., Lüneburg, N., Schwedhelm, E., Ayers, C. R., Anderssohn, M., Khera, A., Atzler, D., de Lemos, J. A., Grant, P. J., McGuire, D. K., et al. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.301219 · Cited by 69
Self-citation
Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease
Lorenzen, J. M., Krämer, R., Kliem, V., Bode‐Böger, S. M., Veldink, H., Haller, H. G., Fliser, D., & Kielstein, J. T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02271.x · Cited by 70
Pathogenic Cycle Between the Endogenous Nitric Oxide Synthase Inhibitor Asymmetrical Dimethylarginine and the Leukocyte-Derived Hemoprotein Myeloperoxidase
von Leitner, E.-C., Klinke, A., Atzler, D., Slocum, J. L., Lund, N., Kielstein, J. T., Maas, R., Schmidt-Haupt, R., Pekarová, M., Hellwinkel, O., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.060541 · Cited by 66
Self-citation
Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1)
Strobel, J., Mieth, M., Endreß, B., Auge, D., König, J., Fromm, M. F., & Maas, R. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.06.002 · Cited by 67
Self-citation
Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study
Notsu, Y., Yano, S., Shibata, H., Nagai, A., & Nabika, T. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.030 · Cited by 66
The Role of Asymmetric Dimethylarginine and Arginine in the Failing Heart and Its Vasculature
Visser, M., Paulus, W. J., Vermeulen, M. A. R., Richir, M. C., Davids, M., Wisselink, W., de Mol, B. A. J. M., & van Leeuwen, P. A. M. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq158 · Cited by 66
Cardiomyocyte dimethylarginine dimethylaminohydrolase1 attenuates left-ventricular remodeling after acute myocardial infarction: involvement in oxidative stress and apoptosis
Hou, L., Guo, J., Xu, F., Weng, X., Yue, W., & Ge, J. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0685-y · Cited by 58
Serum reference intervals of homoarginine, ADMA, and SDMA in the Study of Health in Pomerania
Atzler, D., Schwedhelm, E., Nauck, M. A., Ittermann, T., Böger, R. H., & Friedrich, N. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0314 · Cited by 64
Self-citation
Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study
Siegerink, B., Maas, R., Vossen, C. Y., Schwedhelm, E., Köenig, W., Böger, R. H., Rothenbacher, D., Brenner, H., & Breitling, L. P. (2012) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0515-4 · Cited by 63
Self-citation
Asymmetric Dimethylarginine Reference Intervals Determined with Liquid Chromatography–Tandem Mass Spectrometry: Results from the Framingham Offspring Cohort
Schwedhelm, E., Xanthakis, V., Maas, R., SULLIVAN, L. M., Schulze, F., Riederer, U., Benndorf, R. A., Böger, R. H., & Vasan, R. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.124263 · Cited by 62
Self-citation
Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
Palomo, I. F., Contreras, A., Alarcón, M. A., Elba Leiva, M., Guzmán, L., Mujica, V., Icaza, G., Díaz, N. S., González, D. R., & Moore‐Carrasco, R. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.03.002 · Cited by 63
Effect of asymmetric dimethylarginine (ADMA) on heart failure development
Liu, X., Hou, L., Xu, D., Chen, A., Yang, L., Zhuang, Y., Xu, Y., Fassett, J. T., & Chen, Y. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.02.006 · Cited by 61
Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis
Zhou, S., Zhu, Q., Li, X., Chen, C., Liu, J., Ye, Y., Ruan, Y., & Hei, Z. (2017) · Scientific Reports · doi:10.1038/srep44692 · Cited by 60
Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine
Sena, C. M., Gonçalves, L. M. M., & Seiça, R. M. F. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00280-7 · Cited by 60
Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
Tain, Y., & Huang, L. (2011) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(11)60012-0 · Cited by 57
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease
Böger, R. H., Endres, H. G., Schwedhelm, E., Darius, H., Atzler, D., Lüneburg, N., von Stritzky, B., Maas, R., Thiem, U., Benndorf, R. A., et al. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02322.x · Cited by 57
Self-citation
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
Çavuşoğlu, E., Ruwende, C., Chopra, V., Poludasu, S., Yanamadala, S., Frishman, W. H., Eng, C., Pinsky, D. J., & Marmur, J. D. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.034 · Cited by 57
Asymmetric dimethylarginine exacerbates Aβ-induced toxicity and oxidative stress in human cell and Caenorhabditis elegans models of Alzheimer disease
Luo, Y., Yue, W., Quan, X., Wang, Y., Zhao, B., & Lu, Z. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.12.002 · Cited by 55
Estimated GFR Is Biased by Non-Traditional Cardiovascular Risk Factors
Melsom, T., Fuskevåg, O., Mathisen, U. D., Strand, H., Schei, J., Jenssen, T. G., Solbu, M. D., & Eriksen, B. O. (2015) · American Journal of Nephrology · doi:10.1159/000371557 · Cited by 56
Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus
Ganz, T., Wainstein, J., Gilad, S., Limor, R., Boaz, M., & Stern, N. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2836 · Cited by 54
L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population
van der Zwan, L., Davids, M., Scheffer, P. G., Dekker, J. M., Stehouwer, C. D. A., & Teerlink, T. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e32836037fb · Cited by 53
The issue of plasma asymmetric dimethylarginine reference range – A systematic review and meta-analysis
Németh, B., Ajtay, Z., Hejjel, L., Ferenci, T., Ábrám, Z., Murányi, E., & Kiss, I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177493 · Cited by 53
Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria
Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Teerlink, T., Hansen, T. W., Parving, H., Jacobsen, P. K., & Rossing, P. R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0569-8 · Cited by 53
Long-Term Intermittent Work at High Altitude: Right Heart Functional and Morphological Status and Associated Cardiometabolic Factors
Brito, J., Siqués, P., López, R., Romero, R. S. N., Lèon‐Velarde, F., Flores, K., Lüneburg, N., Hannemann, J., & Böger, R. H. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00248 · Cited by 52
Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? — A scoping review
Nowroozpoor, A., Gutterman, D. D., & Safdar, B. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.104123 · Cited by 52
Robotic treadmill training improves cardiovascular function in spinal cord injury patients
Turiel, M., Sitia, S., Cicala, S., Magagnin, V., Bo, I., Porta, A., Caiani, E. G., Ricci, C., Licari, V., Colonna, V. D. G., et al. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.02.010 · Cited by 53
Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)
Strobel, J., Müller, F., Zolk, O., Endreß, B., König, J., Fromm, M. F., & Maas, R. (2013) · Amino Acids · doi:10.1007/s00726-013-1556-3 · Cited by 53
Self-citation
Arterial remodeling and atherosclerosis: miRNAs involvement
Quintavalle, M., Condorelli, G., & Elia, L. (2011) · Vascular Pharmacology · doi:10.1016/j.vph.2011.08.216 · Cited by 49
Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases
Li, C., Yang, J., Wang, Y., Qi, Y., Yang, W., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01247 · Cited by 51
Effects of propolis, caffeic acid phenethyl ester, and pollen on renal injury in hypertensive rat: An experimental and theoretical approach
Salmas, R. E., Gülhan, M. F., Durdağı, S., Şahna, E., Abdullah, H. I., & Selamoğlu, Z. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3277 · Cited by 50
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis
Ortíz, A., Massy, Z. A., Fliser, D., Lindholm, B., Więcek, A., Martínez‐Castelao, A., Covic, A. C., Goldsmith, D. J. A., Süleymanlar, G., London, G. M., et al. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.170 · Cited by 50
Effects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic Angina
Morita, M., Sakurada, M., Watanabe, F., Yamasaki, T., Doi, H., Ezaki, H., Morishita, K., & Miyake, T. (2013) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/18715222113139990008 · Cited by 49
Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study
Molnos, S., Wahl, S., Haid, M., Eekhoff, E. M. W., Pool, R., Floegel, A., Deelen, J., Much, D., Prehn, C. P., Breier, M., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4436-7 · Cited by 50
DDAH Says NO to ADMA
Cooke, J. P., & Ghebremariam, Y. T. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.228833 · Cited by 49
Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine
Yuan, Q., Hu, C.-P., Gong, Z., Bai, Y., Liu, S., Li, Y., & Jiang, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.050 · Cited by 47
Proton pump inhibitors and vascular function: A prospective cross-over pilot study
Ghebremariam, Y. T., Cooke, J. P., Khan, F., Thakker, R., Chang, P., Shah, N. H., Nead, K. T., & Leeper, N. J. (2015) · Vascular Medicine · doi:10.1177/1358863x14568444 · Cited by 45
Distribution of Asymmetric Dimethylarginine among 980 Healthy, Older Adults of Different Ethnicities
Sydow, K., Fortmann, S. P., Fair, J. M., Varady, A. N., Hlatky, M. A., Go, A. S., Iribarren, C., Tsao, P. S., & for the ADVANCE Investigators (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.136200 · Cited by 47
Paradoxical effect of l-arginine: Acceleration of endothelial cell senescence
Scalera, F., Closs, E. I., Flick, E., Martens‐Lobenhoffer, J., Boissel, J., Lendeckel, U., Heimburg, A., & Bode‐Böger, S. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.091 · Cited by 45
The L-Arginine–Asymmetric Dimethylarginine Ratio is an Independent Predictor of Mortality in Dilated Cardiomyopathy
Anderssohn, M., Rosenberg, M., Schwedhelm, E., Zugck, C., Lutz, M., Lüneburg, N., Frey, N., & Böger, R. H. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.10.011 · Cited by 44
Self-citation
Inflammatory/oxidative stress during the first week after different types of cardiac surgery
Karu, I., Taal, G., Zilmer, K., Pruunsild, C., Starkopf, J., & Zilmer, M. (2010) · Scandinavian Cardiovascular Journal · doi:10.3109/14017430903490981 · Cited by 44
Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases
Dimitroulas, T., Sandoo, A., & Kitas, G. D. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012315 · Cited by 46
Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients
Shafi, T., Hostetter, T. H., Meyer, T. W., Hwang, S., Hai, X., Melamed, M. L., Banerjee, T., Coresh, J., & Powe, N. R. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.033 · Cited by 43
Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infections
Nickler, M., Ottiger, M., Steuer, C., Huber, A., Anderson, J. B., Müller, B., & Schüetz, P. (2015) · Respiratory Research · doi:10.1186/s12931-015-0283-6 · Cited by 42
N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarctionN-3 PUFA supplementation in acute myocardial infarction.
Haberka, M., Mizia‐Stec, K., Mizia, M., Janowska, J., Gieszczyk-Strózik, K., Chmiel, A., Zahorska‐Markiewicz, B., & Gąsior, Z. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.07.011 · Cited by 41
In vivo evidence that Agxt2 can regulate plasma levels of dimethylarginines in mice
Kittel, A., Maas, R., König, J., Mieth, M., Weiss, N., Jarzebska, N., Hohenstein, B., Martens‐Lobenhoffer, J., Bode‐Böger, S. M., & Rodionov, R. N. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.008 · Cited by 41
Self-citation
Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease
Fliser, D. (2010) · Journal of Nephrology · doi:10.1093/joneph/23.4.369 · Cited by 41
Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study
Sandoo, A., Dimitroulas, T., Hodson, J. A., Smith, J., Douglas, K., & Kitas, G. D. (2014) · Rheumatology · doi:10.1093/rheumatology/keu349 · Cited by 40
Endothelin-A Receptor Antagonism Modifies Cardiovascular Risk Factors in CKD
Dhaun, N., Melville, V., Blackwell, S., Talwar, D. K., Johnston, N. R., Goddard, J. G., & Webb, D. J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040355 · Cited by 40
Carotid Plaque Score and Risk of Cardiovascular Mortality in the Oldest Old: Results from the TOOTH Study
Hirata, T., Arai, Y., Takayama, M., Abe, Y., Ohkuma, K., & Takebayashi, T. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.37911 · Cited by 40
HPLC analysis of asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine and arginine in small plasma volumes using a Gemini-NX column at high pH
Jones, C. E., Darcy, C. J., Woodberry, T., Anstey, N. M., & McNeil, Y. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.10.035 · Cited by 39
Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
Elçi, E., Kaya, C., Çim, N., Yıldızhan, R., & Elçi, G. G. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1203893 · Cited by 39
Associations of Methylarginines and Homoarginine With Diastolic Dysfunction and Cardiovascular Risk Factors in Patients With Preserved Left Ventricular Ejection Fraction
Pilz, S., Edelmann, F., Meinitzer, A., Gelbrich, G., Döner, U., Düngen, H., Tomaschitz, A., Kienreich, K., Gaksch, M., Duvinage, A., et al. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.09.004 · Cited by 38
Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction
Xu, X. Y., Zhang, P., Kwak, D., Fassett, J. T., Yue, W., Atzler, D., Hu, X., Liu, X., Wang, H., Lu, Z., et al. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0644-z · Cited by 37
Self-citation
MicroRNA-mediated vascular intercellular communication is altered in chronic kidney disease
Zietzer, A., Steffen, E., Niepmann, S. T., Düsing, P., Hosen, M. R., Liu, W., Jamme, P., Al‐Kassou, B., Goody, P. R., Zimmer, S., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa322 · Cited by 37

Authors: Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S.
Affiliations: From the Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (R.H.B., E.S., R.M., F.S., R.A.B.); Framingham Heart Study, Framingham, Mass (L.M.S., T.J.W., E.J.B., V.X., R.S.V.); Department of Biostatistics (L.M.S., V.X.) and Cardiology Division and Preventive Medicine (E.J.B., R.S.V.), Boston University School of Public Health, Boston, Mass; and Cardiology Division, Massachusetts General Hospital, Boston (T.J...
Boston University (US)
ORCID: Sullivan, Lisa M.
Schwedhelm, Edzard
Wang, Thomas J.
Maas, Renke
Benjamin, Emelia J.
Schulze, Friedrich
Xanthakis, Vanessa
Benndorf, Ralf A.
Vasan, Ramachandran S.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2009-03-31
Volume: 119
Issue: 12
Pages: 1592-1600
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.838268
PMC: PMC2742491
OpenAlex: W2136960413
Cited by: 351
References: 41
Citations by year: 2026: 2 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 17 · 2021: 10 · 2020: 20 · 2019: 15 · 2018: 21 · 2017: 21 · 2016: 24 · 2015: 33 · 2014: 29 · 2013: 21 · 2012: 29
FWCI: 23.49
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Deutsche Forschungsgemeinschaft
National Institutes of Health (5k23hl074077-03, n01hc25195-41-0-1, n01hv28178-12-0-0)
National Heart, Lung, and Blood Institute (K23 HL074077-01, 2K24 HL 04334, N01‐HC25195, K23-HL-074077, K24HL004334, N01-HC-025195, N01-HV-028178)
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: asymmetric dimethylarginine, L-arginine, endothelial dysfunction, nitric oxide synthase inhibition, cardiovascular disease incidence, all-cause mortality, cardiovascular mortality, diabetes mellitus, Framingham Offspring Study, community-based cohort, prognostic factors
MeSH terms: Aged, Arginine, Cardiovascular Diseases, Cause of Death, Diabetes Mellitus, Follow-Up Studies, Humans, Middle Aged, Mortality, Predictive Value of Tests, Prognosis, Incidence, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks